Results 221 to 230 of about 180,278 (321)

The evolving landscape of biomarkers for systemic therapy in advanced hepatocellular carcinoma. [PDF]

Biomark Res
Guo X, Zhao Z, Zhu L, Liu S, Zhou L, Wu F, Fang S, Chen M, Zheng L, Ji J.   +9 more
europepmc   +1 more source

Antigen processing in vivo and the elicitation of primary CTL responses. [PDF]

, 1995
Nicholas P. Restifo, Igor Bačík, Kari R. Irvine, Jonathan W. Yewdell, Brian J. McCabe, Ronald Anderson, Laurence C. Eisenlohr, Steven A. Rosenberg, Jack R. Bennink   +8 more
openalex   +1 more source

Pulse‐Level Quantum Robust Control with Diffusion‐Based Reinforcement Learning

Advanced Physics Research, EarlyView.
This paper proposes a diffusion‐based reinforcement learning method for pulse‐level quantum robust control (PQC‐DBRL) to enhance the robustness of pulse‐level quantum gate control. When evaluated across different Hamiltonian variations, PQC‐DBRL shows a smaller fidelity variance compared to GRAPE, indicating higher robustness against system parameter ...
Yuanjing Zhang, Tao Shang, Chenyi Zhang, Xueyi Guo   +3 more
wiley   +1 more source

Delayed regional metastasis from small face/scalp cutaneous squamous carcinoma: outcomes and predictors. [PDF]

Arch Dermatol Res
Shires CB, Boughter JD, Golembeski CP, Sharp NM, Hall AT, Sebelik ME.   +5 more
europepmc   +1 more source

Characterization of the Peptide Binding Motif of a Rhesus MHC Class I Molecule (Mamu-A*01) That Binds an Immunodominant CTL Epitope from Simian Immunodeficiency Virus [PDF]

, 1998
Todd M. Allen, John Sidney, Marie‐France del Guercio, Rhona L. Glickman, Gary L. Lensmeyer, Donald A. Wiebe, Robert DeMars, C. David Pauza, R. Paul Johnson, Alessandro Sette, David I. Watkins   +10 more
openalex   +1 more source

Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial

Arthritis &Rheumatology, EarlyView.
Objective Our objective was to evaluate the efficacy and safety of subcutaneous (SC) abatacept and standard of care (SOC) for the treatment of idiopathic inflammatory myopathy (IIM) over 52 weeks. Methods In this randomized, double‐blind, placebo‐controlled phase III trial, patients with treatment‐refractory IIM received SC abatacept (at 125 mg weekly)
Rohit Aggarwal, Ingrid E. Lundberg, Yeong‐Wook Song, Aziz Shaibani, Victoria P. Werth, Michael A. Maldonado   +5 more
wiley   +1 more source

Exploring the tumor microenvironment of breast cancer to develop a prognostic model and predict immunotherapy responses. [PDF]

Sci Rep
Tian Y, Yang Y, He L, Yu X, Zhou H, Wang J.   +5 more
europepmc   +1 more source

Identification of New HER2/neu-Derived Peptide Epitopes That Can Elicit Specific CTL Against Autologous and Allogeneic Carcinomas and Melanomas [PDF]

, 1999
Rongcun Yang, Flavio Salazar‐Onfray, Jehad Charo, Karl‐Johan Malmberg, Kristina Evrin, Hubert Maes, Koji Kono, Christina Hising, Max Petersson, Olle Larsson, Lan Li, Ettore Appella, Alessandro Sette, Esteban Celis, Rolf Kiessling   +14 more
openalex   +1 more source

Metabolic Stress Expands Polyfunctional, Proinflammatory Th17 Cells in Patients With Psoriatic Arthritis for Whom There is Interleukin‐23–Independent Interleukin‐17 Production

Arthritis &Rheumatology, EarlyView.
Objective Genetic associations and blockade of the interleukin (IL)‐23/IL‐17 axis with monoclonal antibodies support a role for this pathway in patients with psoriatic arthritis (PsA). This study examines the requirement of IL‐23 for IL‐17 production and the role of the metabolic microenvironment in the expansion of Th17‐derived cells in patients with ...
Carmel B. Stober, Louise Ellis, Jane C. Goodall, Marc Veldhoen, J. S. Hill Gaston   +4 more
wiley   +1 more source

The R-RAS2 GTPase is a signaling hub in triple-negative breast cancer cell metabolism and metastatic behavior. [PDF]

J Hematol Oncol
Cifuentes C, Horndler L, Grosso P, Oeste CL, Hortal AM, Castillo J, Fernández-Pisonero I, Paradela A, Bustelo X, Alarcón B.   +9 more
europepmc   +1 more source